Hyperhomocysteinemia, coronary heart disease, and diabetes mellitus as predicted by various definitions for metabolic syndrome in a hypertensive Saudi population

Saudi Medical Journal

Volumn 28, Issue 3, 2007, Pages 339-346

  Al Daghri, Nasser M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; DIABETES MELLITUS; ELECTROCHEMICAL DETECTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREDICTION; PREVALENCE; QUESTIONNAIRE; RISK ASSESSMENT; SAUDI ARABIA; UNIVERSITY HOSPITAL;

ADULT; AGE DISTRIBUTION; AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMORBIDITY; CONFIDENCE INTERVALS; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROBABILITY; QUESTIONNAIRES; RISK ASSESSMENT; SAUDI ARABIA; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 34247178640     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Vague J. The degree of masculine differentiation of obesities: A risk factor for determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956; 4: 20-34.
2. Haller H. Epidemiologie und assoziierte riskofactoren der hyperlipoproteinamie (Epidemiology and associated risk factors of hyperlipoprotenemia). Z Gesamte Inn Med 1977; 32: 124-128.
3. Reaven GM. Banting Iecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
4. Alberti KG and Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications: Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
5. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III. JAMA 2001; 285: 2486-2497.
6. International Diabetes Federation. New IDF worldwide definition of the metabolic syndrome. Press conference, 1st International Congress on "Pre-diabetes" and the metabolic syndrome. Berlin Germany: International Diabetes Federation.; 2005.
7. Fodor JG, Le Grand C. Homocysteine: A new coronary heart disease risk factor. University of Ottawa Heart Institute Prevention and Rehabilitation Center: CACR Newsletter; 1999.
8. Troughton JA, Woodside JV, Young IS, Arveiler D, Amouyel P, Ferrieres J, et al. Homocysteine and coronary heart disease in the PRIME study. Atherosclerosis 2006; 13; [Epub ahead of print].
9. Clarke R, Lewington S. Homocysteine and coronary heart disease. Semin Vasc Med 2002; 2; 391-399.
10. Shai I, Stampfer MJ, Ma J, Manson JE, Harkinson SE, Cannuscio C, et al. Homocysteine as a risk factor for coronary heart disease and its association with inflammatory biomarkers, lipids, and dietary risk factors. Atherosclerosis 2004; 177: 375-381.
11. von Eckardstein A. Risk factors for atherosclerotic vascular disease. Handb Exp Pharmacol 2005; 170: 71-105.
12. Eaton CB. Traditional and emerging risk factors for cardiovascular disease. Prim Care 2005; 32: 963-976.
13. Weikert C, Hoffman K, Dierkes J, Zyriax BC, Klipstein-Grobusch K, Schulze MB, et. al. A homocysteine metabolism-related dietary pattern and the risk of coronary heart disease in two independent German study populations. J Nutr 2005; 135: 1981-1988.
14. Al-Nozha M, Al-Khadra A, Arafah MR, Al-Maatouq MA, Khalil MZ, Khan NB, et. al. Metabolic syndrome in Saudi Arabia. Saudi Med J 2005; 26: 1918-1925.
15. Ramsey LE, Williams B, Johnston GD, Mac Gregor GA, Poston I, Potter JF, et al. 1999 Guidelines for management of hypertension: report of the third working party of the British hypertension society. Journal of Human Hypertension 1999; 13: 569-592.
16. Martin SC, Tsakas-Ampatzis I, Bartlett WA, and Jones AF. Measurement of plasma total homocysteine by HPLC with coulometric detection. Clin Chem 1999; 45: 150-152.
17. Deepa M, Farooq S, Datta M, Deepa R, and Mohan V. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chemical Urban Rural Epidemiology Study (CURES-34). Diabetes/Metabolism Research and Reviews 2006; 5: [advance of print].
18. Ford, ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 2005; 28: 2745-2749.
19. Harzallah F, Alberti H, and Khalifa FB. The metabolic syndrome in an Arab population: a first look at the new International Diabetes Federation criteria. Diabetic Medicine 2006; 23: 441-444.
20. Miyaki K, Hara A. Naito M, Naito T, and Nakayama T. Two new criteria of the metabolic syndrome: Prevalence and the association of brachial-ankle pulse wave velocity in Japanese male workers. J Occup Health 2005; 47: 134-140.
21. Ford ES, Giles WH. A comparison of the prevalence of metabolic syndrome using two proposed definitions. Diabetes Care 2003; 26: 575-581.
22. Adams RJ, Appleton S, Wilson DH. Population comparison of two clinical approaches to metabolic syndrome. Implications of the new international diabetes federation consensus definition. Diabetes Care 2005; 28: 2777-2779.
23. Guerrero-Romero F and Rodriguez-Moran M. Concordance between the 2005 International Diabetes Federation definition for diagnosing metabolic syndrome with the National Cholesterol Education Program Adult Treatment Panel III and the World Health Organization definitions. Diabetes Care 2005; 28: 2588-2589.
24. McCully KS and Wilson RB. Homocysteine theory of arteriosclerosis. Atherosclerosis 1975; 22: 215-227.
25. McCully KS. Vascular pathology of homocystinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56: 111-128.